14 ACTUAT fluticasone furoate 0.2 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler
RxNorm concept 1648783, clinical drug (scd). Prescribable name: fluticasone furoate/vilanterol 200/25 MCG/INHAL Dry Powder Inhaler, 14 Blisters.
- RxCUI
- 1648783
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1648783 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- vilanterol 0.025 MG/ACTUAT (SCDC, consists of)
- fluticasone furoate 0.2 MG/ACTUAT (SCDC, consists of)
- Dry Powder Inhaler (DF, has dose form)
- 14 ACTUAT fluticasone furoate 0.2 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler [Breo] (SBD, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1648783 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1648783 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1648783. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.